Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001943462-24-000008
Filing Date
2024-12-16
Accepted
2024-12-16 16:18:07
Documents
1
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 2009
  Complete submission text file 0001943462-24-000008.txt   3986
Mailing Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087
Business Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087 (484) 253-1461
PALVELLA THERAPEUTICS, INC. (Issuer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 283 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830
Business Address 283 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830 203-632-6341
Dellora Investments LP (Reporting) CIK: 0001943462 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 241552055